Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)
Contact +33 (0)3 90 20 54 70
📢 -40% on Recombinant Antibody Production. Available until November 16th on your first order. Code: RECAB40

Biosimilar Stable Cell Pools
antibodies

Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

  • 60+ biosimilar cell pools available
  • Validated for reference therapeutics
  • Custom antibodies/proteins expressing cell pools
  • High yields

Request more information

Explore our Ready-to-use Stable Cell Pools for Therapeutic Antibody Development

Accelerate your path to therapeutic antibodies with our portfolio of well-characterized, high-expression stable cell pools.

Whether you are advancing biosimilar programs with gold-standard antibodies or driving the development of novel biologics, our off-the-shelf monoclonal cell pools are optimized for high-speed monoclonal development and bulk production!

Ask for your fast monoclonal development or for a bulk quantity of therapeutic antibody below !

Need to express your antibody or protein in a

cell line tailored to your needs?

Discover our custom cell line services

Featured Stable Cell Pools:

Each stable cell pool is developed using our proprietary expression platform and quality-controlled
to ensure robust and consistent antibody production.

Name of therapeutics (pool) Target Isotype Yield Therapeutic Area
Cetuximab hEGFR IgG1 Between 5g/L and 10g/L Oncology
Rituximab MS4A1 IgG1 Between 5g/L and 10g/L Immunotherapy
Ramucirumab VEGFR-2 IgG1Kappa Between 5g/L and 10g/L Oncology
Infliximab TNF-alpha IgG1 Between 5g/L and 10g/L Inflammation
Adalimumab TNF-alpha IgG1 Between 5g/L and 10g/L Inflammation
Nivolumab PD-1 IgG4 Between 5g/L and 10g/L Immunotherapy
Bevacizumab VEGF IgG1 Between 5g/L and 10g/L Oncology
Panitumumab EGFR IgG2-kappa Between 5g/L and 10g/L Oncology
Ustekinumab Human IL-12 IL-23 IgG1 Between 5g/L and 10g/L Inflammation
Ranibizumab VEGF FabG1 Between 5g/L and 10g/L Oncology
Ipilimumab CTLA-4 IgG1Kappa Between 5g/L and 10g/L Immunotherapy
Natalizumab ITGA4, CD49d IgG4-kappa Between 5g/L and 10g/L Inflammation
Daclizumab IL2RA IgG1-kappa Between 5g/L and 10g/L Inflammation
Palivizumab RSV IgG1-kappa Between 5g/L and 10g/L Virology
Belimumab TNFSF13B, CD257 IgG1-lambda Between 5g/L and 10g/L Immunology
Denosumab RANKL IgG2Kappa Between 5g/L and 10g/L Developmental Biology

Need to test the efficiency of your new drug candidate ?

Discover our biosimilar library

Why Choose our Stable Cell Pools?

High-yield & scalable CHO cell systems
Our cell pools are based on optimized CHO expression systems to ensure high productivity and seamless scalability, from lab-scale testing to large-scale bioproduction.
Expression of clinically validated monoclonal antibodies
Each stable cell pool expresses a monoclonal antibody referenced in clinical applications, ensuring biological relevance and reliable benchmarking for biosimilar development.
Quality controlled & sequence verified
All cell pools undergo strict QC procedures, including sequence verification, stability checks, and expression profiling to guarantee batch-to-batch consistency.
No royalties
ProteoGenix has selected parent royalty-free cell lines and owns its proprietary cell line, allowing you complete freedom for the future of your project.
Ideal for biosimilar R&D, validation, or early-stage production
Designed for flexibility, our cell pools are suited for analytical method development, comparative studies, and pilot-scale manufacturing in biosimilar pipelines.

FAQ

Request More Information

Interested in pricing or additional details for your project?
Fill out the form below and our scientific team will get back to you within 24 hours.

    Cart (0 Items)

    Your cart is currently empty.

    View Products